PFE - Alnylam appealing patent ruling in case against Moderna
2023-08-28 16:16:00 ET
More on Alnylam Pharmaceuticals
- Alnylam: Unlimited Promise Or Unlimited Losses?
- Alnylam: Zilebesiran Deal With Roche Reveals A Very Long Development Timeline
- Roche, Alnylam in pact for blood pressure candidate
- Alnylam to face FDA AdCom meeting on amyloidosis drug
- Alnylam upgraded to outperform at BMO on pipeline opportunities
- Seeking Alpha’s Quant Rating on Alnylam Pharmaceuticals
- Earnings data for Alnylam Pharmaceuticals
For further details see:
Alnylam appealing patent ruling in case against Moderna